Dana Cruz, DO
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cruz’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,583
Medicare paid this office $1,583 for 29 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
29 Original Medicare patients in 2024. Average age 71 · Health risk score 1.92. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 55%.
The office billed $19,052, Medicare allowed $2,082 and paid $1,583; for 40 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 29 | 40 | 71 | 1.92 | $19,052 | $1,583 |
| 2023 | 21 | 29 | 71 | 2.45 | $15,418 | $1,313 |
| 2022 | 28 | 34 | 72 | 1.29 | $15,937 | $1,843 |
| 2021 | 26 | 35 | 70 | 1.06 | $16,894 | $1,387 |
| 2020 | 29 | 34 | 69 | 1.19 | $13,830 | $1,640 |
| 2019 | 58 | 92 | 72 | 1.30 | $38,704 | $2,969 |
| 2018 | 52 | 72 | 69 | 1.27 | $23,615 | $2,389 |
| 2017 | 42 | 57 | 69 | 1.38 | $16,097 | $1,615 |
| 2016 | 33 | 47 | 72 | 1.42 | $11,710 | $954 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| Screening mammography | 11 | $1,466 | $133 |
2019: 1 service
| X-ray of chest, 2 views | 14 | $223 | $14 |
2018: 1 service
| Screening mammography | 12 | $1,612 | $134 |
Medicaid work
$370,025 in 2024
Medicaid paid $370,025 for 7,637 billed services this clinician did in 2024, up to 79 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 596 | $306,237 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 137 | $62,153 |
| Short return visit (20+ min) | 882 | $509 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 14 | $350 |
| Return visit (30+ min) | 387 | $245 |
| Hemoglobin A1C level | 204 | $122 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 27 | $101 |
| Thyroid stimulating hormone (TSH) | 128 | $96 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 214 | $75 |
| Blood test, lipids (cholesterol and triglycerides) | 70 | $60 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 17 | $32 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 56 | $22 |
| 2024 | 7,637 | 31 | 79 | $370,025 |
| 2023 | 5,976 | 31 | 81 | $394,120 |
| 2022 | 4,095 | 27 | 106 | $282,103 |
| 2021 | 5,081 | 27 | 109 | $491,615 |
| 2020 | 4,400 | 20 | 112 | $337,574 |
| 2019 | 5,206 | 20 | 166 | $413,522 |
| 2018 | 4,851 | 20 | 165 | $492,897 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 773 | $381,577 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 16 | $6,770 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 12 | $1,573 |
| Short return visit (20+ min) | 1,015 | $1,452 |
| Return visit (30+ min) | 436 | $908 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 12 | $300 |
| Hemoglobin A1C level | 325 | $241 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 19 | $231 |
| Thyroid stimulating hormone (TSH) | 232 | $223 |
| Blood test, lipids (cholesterol and triglycerides) | 150 | $186 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 59 | $165 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 445 | $99 |
2022
| Clinic visit/encounter, all-inclusive | 575 | $277,557 |
| Short return visit (20+ min) | 786 | $1,918 |
| Short return visit | 362 | $773 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 15 | $600 |
| Return visit (30+ min) | 185 | $320 |
| Thyroid stimulating hormone (TSH) | 148 | $177 |
| Hemoglobin A1C level | 226 | $172 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 219 | $110 |
| Blood test, lipids (cholesterol and triglycerides) | 98 | $90 |
| HEPATIC FUNCTION PANEL | 32 | $71 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 32 | $60 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 65 | $55 |
2021
| Clinic visit/encounter, all-inclusive | 1,026 | $483,815 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 49 | $1,960 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 31 | $1,240 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 27 | $1,080 |
| Short return visit (20+ min) | 855 | $1,039 |
| Short return visit | 751 | $843 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 14 | $560 |
| Thyroid stimulating hormone (TSH) | 169 | $308 |
| Hemoglobin A1C level | 220 | $210 |
| Return visit (30+ min) | 125 | $162 |
| ELECTROLYTE PANEL | 184 | $82 |
| Blood test, lipids (cholesterol and triglycerides) | 75 | $65 |
2020
| Clinic visit/encounter, all-inclusive | 1,047 | $334,018 |
| Return visit (30+ min) | 507 | $1,134 |
| Short return visit (20+ min) | 573 | $778 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 144 | $534 |
| Short return visit | 509 | $293 |
| Thyroid stimulating hormone (TSH) | 152 | $216 |
| Hemoglobin A1C level | 222 | $162 |
| Blood test, lipids (cholesterol and triglycerides) | 104 | $140 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 20 | $81 |
| HEPATIC FUNCTION PANEL | 51 | $50 |
| Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations | 25 | $49 |
| ELECTROLYTE PANEL | 197 | $27 |
2019
| Clinic visit/encounter, all-inclusive | 1,278 | $404,768 |
| Return visit (30+ min) | 1,253 | $5,141 |
| Short return visit (20+ min) | 366 | $1,577 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 97 | $371 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 55 | $345 |
| Thyroid stimulating hormone (TSH) | 171 | $328 |
| Hemoglobin A1C level | 274 | $315 |
| HEPATIC FUNCTION PANEL | 149 | $168 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 204 | $159 |
| Blood test, lipids (cholesterol and triglycerides) | 131 | $140 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 126 | $88 |
| HEPATITIS C ANTIBODY | 16 | $36 |
2018
| Clinic visit/encounter, all-inclusive | 1,554 | $485,324 |
| Return visit (30+ min) | 1,078 | $5,059 |
| Short return visit (20+ min) | 247 | $1,164 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 156 | $280 |
| Thyroid stimulating hormone (TSH) | 163 | $242 |
| HEPATIC FUNCTION PANEL | 182 | $154 |
| Blood test, lipids (cholesterol and triglycerides) | 97 | $150 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $148 |
| Hemoglobin A1C level | 139 | $148 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 91 | $58 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 26 | $51 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 58 | $40 |
Drugs they prescribed that Part D paid
$135,346
Pharmacies billed $135,346 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (16 of 2,096) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,872 generic and fewer than 11 brand-name prescriptions · $135,346 in drug cost · 27 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 18 | $19,426 | $1,079 |
| Januvia | 20 | $17,898 | $895 |
| Tradjenta | 12 | $17,073 | $1,423 |
| Xarelto | 11 | $9,915 | $901 |
| Eliquis | 16 | $9,792 | $612 |
See all 52 drugs
| Jardiance | 18 | $19,426 | $1,079 |
| Januvia | 20 | $17,898 | $895 |
| Tradjenta | 12 | $17,073 | $1,423 |
| Xarelto | 11 | $9,915 | $901 |
| Eliquis | 16 | $9,792 | $612 |
| Arnuity Ellipta | 11 | $2,639 | $240 |
| Fluticasone Propionate Hfa | 15 | $2,535 | $169 |
| Albuterol Sulfate Hfa | 45 | $1,479 | $33 |
| Atorvastatin | 283 | $1,410 | $5 |
| Losartan | 117 | $727 | $6 |
| Tamsulosin | 43 | $609 | $14 |
| Gabapentin | 52 | $582 | $11 |
| Amlodipine Besylate | 189 | $553 | $3 |
| Rivastigmine | 12 | $457 | $38 |
| Propranolol | 18 | $455 | $25 |
| Simvastatin | 42 | $450 | $11 |
| Metoprolol | 37 | $415 | $11 |
| Metformin | 72 | $406 | $6 |
| Omeprazole | 62 | $371 | $6 |
| Levothyroxine | 59 | $353 | $6 |
| Pantoprazole | 35 | $311 | $9 |
| Furosemide | 59 | $284 | $5 |
| Benazepril | 34 | $257 | $8 |
| Fosinopril | 12 | $255 | $21 |
| Fluticasone Propionate | 32 | $236 | $7 |
| Metoprolol | 38 | $230 | $6 |
| Montelukast | 31 | $227 | $7 |
| Rosuvastatin | 40 | $219 | $5 |
| Glipizide | 20 | $213 | $11 |
| Diltiazem 24hr Er (Cd) | 12 | $188 | $16 |
| Hydrocortisone | 18 | $176 | $10 |
| Hydralazine | 17 | $170 | $10 |
| Metformin Hcl Er | 34 | $167 | $5 |
| Oxybutynin Chloride Er | 16 | $152 | $10 |
| Duloxetine | 13 | $135 | $10 |
| Finasteride | 15 | $135 | $9 |
| Famotidine | 22 | $132 | $6 |
| Pravastatin | 16 | $130 | $8 |
| Nyamyc | 13 | $127 | $10 |
| Carvedilol | 24 | $120 | $5 |
| Lisinopril | 22 | $110 | $5 |
| Allopurinol | 14 | $102 | $7 |
| Atenolol | 27 | $100 | $4 |
| Alendronate | 15 | $92 | $6 |
| Trazodone | 13 | $83 | $6 |
| Valacyclovir | 11 | $81 | $7 |
| Clopidogrel | 18 | $76 | $4 |
| Ezetimibe | 11 | $76 | $7 |
| Hydrochlorothiazide | 28 | $65 | $2 |
| Hydrocodone-Acetaminophen | 13 | $64 | $5 |
| Naproxen | 14 | $39 | $3 |
| Baclofen | 12 | $33 | $3 |
Year by year
| 2024 | 2,096 | 188 | 1% (16) | None | $135,346 |
| 2023 | 2,214 | 174 | 2% (33) | None | $167,907 |
| 2022 | 2,422 | 230 | 1% (26) | 11% | $163,071 |
| 2021 | 2,878 | 227 | 2% (61) | None | $137,807 |
| 2020 | 2,954 | 215 | 2% (57) | 15% | $132,944 |
| 2019 | 2,466 | 221 | 2% (60) | 16% | $114,766 |
| 2018 | 1,826 | 216 | 4% (75) | None | $91,569 |
| 2017 | 1,324 | 225 | 6% (74) | None | $64,214 |
| 2016 | 673 | 176 | 4% (27) | None | $40,439 |
| 2015 | 600 | 88 | 3% (16) | None | $30,265 |
| 2014 | 299 | 39 | 8% (24) | None | $14,422 |
| 2013 | 118 | 20 | None | 19% | $9,899 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 44 drugs
| Januvia | 41 | $37,206 | $907 |
| Eliquis | 15 | $11,091 | $739 |
| Flovent Hfa | 33 | $7,380 | $224 |
| Advair Diskus | 12 | $4,884 | $407 |
| Atorvastatin | 265 | $4,660 | $18 |
| Sucralfate | 23 | $4,127 | $179 |
| Losartan | 112 | $2,198 | $20 |
| Amlodipine Besylate | 194 | $2,046 | $11 |
| Rivastigmine | 11 | $1,298 | $118 |
| Tamsulosin | 40 | $1,209 | $30 |
| Metformin | 87 | $1,173 | $13 |
| Famotidine | 38 | $1,158 | $30 |
| Levothyroxine | 81 | $1,141 | $14 |
| Albuterol Sulfate Hfa | 23 | $1,139 | $50 |
| Gabapentin | 61 | $1,060 | $17 |
| Duloxetine | 17 | $1,021 | $60 |
| Montelukast | 32 | $845 | $26 |
| Fluticasone Propionate | 52 | $835 | $16 |
| Pantoprazole | 24 | $804 | $33 |
| Metoprolol | 30 | $764 | $25 |
| Simvastatin | 41 | $764 | $19 |
| Metoprolol | 41 | $755 | $18 |
| Ventolin Hfa | 11 | $657 | $60 |
| Rosuvastatin | 48 | $643 | $13 |
| Benazepril | 33 | $571 | $17 |
| Omeprazole | 58 | $543 | $9 |
| Glipizide | 43 | $523 | $12 |
| Oxybutynin Chloride Er | 18 | $474 | $26 |
| Fosinopril | 22 | $456 | $21 |
| Metformin Hcl Er | 26 | $435 | $17 |
| Hydralazine | 25 | $398 | $16 |
| Diclofenac | 20 | $395 | $20 |
| Propranolol | 17 | $383 | $23 |
| Furosemide | 63 | $367 | $6 |
| Alendronate | 19 | $318 | $17 |
| Lisinopril | 23 | $281 | $12 |
| Hydrochlorothiazide | 50 | $260 | $5 |
| Atenolol | 31 | $255 | $8 |
| Hydrocodone-Acetaminophen | 20 | $243 | $12 |
| Nitroglycerin | 16 | $166 | $10 |
| Clopidogrel | 15 | $159 | $11 |
| Baclofen | 17 | $115 | $7 |
| Isosorbide Mononitrate Er | 13 | $110 | $8 |
| Nyamyc | 11 | $86 | $8 |
2022: 49 drugs
| Januvia | 43 | $35,349 | $822 |
| Trulicity | 20 | $17,225 | $861 |
| Eliquis | 20 | $12,662 | $633 |
| Flovent Hfa | 43 | $10,746 | $250 |
| Atrovent Hfa | 12 | $6,305 | $525 |
| Sucralfate | 36 | $5,227 | $145 |
| Atorvastatin | 304 | $3,473 | $11 |
| Amlodipine Besylate | 176 | $1,429 | $8 |
| Losartan | 111 | $1,218 | $11 |
| Levothyroxine | 73 | $1,208 | $17 |
| Metformin | 108 | $1,193 | $11 |
| Ventolin Hfa | 19 | $1,185 | $62 |
| Albuterol Sulfate Hfa | 23 | $1,037 | $45 |
| Rivastigmine | 13 | $912 | $70 |
| Metoprolol | 38 | $868 | $23 |
| Famotidine | 54 | $844 | $16 |
| Omeprazole | 67 | $821 | $12 |
| Gabapentin | 78 | $806 | $10 |
| Glipizide | 48 | $756 | $16 |
| Oxybutynin Chloride Er | 23 | $725 | $32 |
| Propranolol | 24 | $712 | $30 |
| Pantoprazole | 28 | $597 | $21 |
| Metformin Hcl Er | 26 | $551 | $21 |
| Tamsulosin | 31 | $523 | $17 |
| Montelukast | 30 | $521 | $17 |
| Simvastatin | 71 | $470 | $7 |
| Ezetimibe | 12 | $453 | $38 |
| Metoprolol | 32 | $443 | $14 |
| Hydrochlorothiazide | 64 | $415 | $6 |
| Benazepril | 27 | $407 | $15 |
| Furosemide | 65 | $383 | $6 |
| Rosuvastatin | 21 | $378 | $18 |
| Fosinopril | 24 | $354 | $15 |
| Atenolol | 54 | $354 | $7 |
| Fluticasone Propionate | 36 | $353 | $10 |
| Potassium Chloride | 12 | $345 | $29 |
| Hydralazine | 23 | $319 | $14 |
| Lisinopril | 44 | $300 | $7 |
| Clotrimazole | 16 | $292 | $18 |
| Alendronate | 28 | $248 | $9 |
| Allopurinol | 14 | $210 | $15 |
| Doxazosin Mesylate | 11 | $196 | $18 |
| Triamcinolone Acetonide | 15 | $184 | $12 |
| Baclofen | 22 | $175 | $8 |
| Nitroglycerin | 15 | $170 | $11 |
| Clopidogrel | 13 | $118 | $9 |
| Hydrocodone-Acetaminophen | 13 | $115 | $9 |
| Sertraline | 15 | $85 | $6 |
| Trazodone | 12 | $72 | $6 |
2021: 56 drugs
| Januvia | 31 | $26,759 | $863 |
| Xarelto | 12 | $11,178 | $932 |
| Eliquis | 14 | $7,135 | $510 |
| Spiriva | 14 | $6,312 | $451 |
| Atrovent Hfa | 15 | $6,272 | $418 |
| Sucralfate | 31 | $5,563 | $179 |
| Lantus Solostar | 12 | $4,222 | $352 |
| Flovent Hfa | 15 | $3,526 | $235 |
| Atorvastatin | 311 | $3,423 | $11 |
| Ventolin Hfa | 36 | $2,157 | $60 |
| Amlodipine Besylate | 258 | $1,635 | $6 |
| Losartan | 146 | $1,460 | $10 |
| Albuterol Sulfate Hfa | 25 | $1,186 | $47 |
| Levothyroxine | 76 | $1,150 | $15 |
| Gabapentin | 95 | $1,084 | $11 |
| Omeprazole | 79 | $983 | $12 |
| Metformin | 125 | $791 | $6 |
| Metoprolol | 54 | $775 | $14 |
| Metoprolol | 71 | $714 | $10 |
| Rosuvastatin | 30 | $700 | $23 |
| Oxybutynin Chloride Er | 17 | $648 | $38 |
| Pantoprazole | 42 | $625 | $15 |
| Famotidine | 60 | $607 | $10 |
| Atenolol | 59 | $509 | $9 |
| Hydrocodone-Acetaminophen | 46 | $498 | $11 |
| Furosemide | 95 | $475 | $5 |
| Fosinopril | 26 | $468 | $18 |
| Propranolol | 21 | $464 | $22 |
| Benazepril | 41 | $444 | $11 |
| Glipizide | 62 | $439 | $7 |
| Simvastatin | 76 | $416 | $5 |
| Diclofenac | 22 | $409 | $19 |
| Potassium Chloride | 16 | $392 | $24 |
| Allopurinol | 26 | $373 | $14 |
| Montelukast | 27 | $350 | $13 |
| Ezetimibe | 17 | $334 | $20 |
| Nitroglycerin | 22 | $322 | $15 |
| Fluticasone Propionate | 35 | $317 | $9 |
| Alendronate | 36 | $294 | $8 |
| Hydrochlorothiazide | 75 | $271 | $4 |
| Clopidogrel | 21 | $253 | $12 |
| Pravastatin | 16 | $233 | $15 |
| Hydralazine | 18 | $227 | $13 |
| Tamsulosin | 36 | $224 | $6 |
| Baclofen | 25 | $176 | $7 |
| Clotrimazole | 13 | $152 | $12 |
| Metformin Hcl Er | 24 | $151 | $6 |
| Lisinopril | 30 | $144 | $5 |
| Carbamazepine | 12 | $130 | $11 |
| Bupropion Xl | 13 | $124 | $10 |
| Cephalexin | 15 | $120 | $8 |
| Trazodone | 14 | $70 | $5 |
| Fluoxetine | 23 | $68 | $3 |
| Sertraline | 11 | $52 | $5 |
| Tramadol | 11 | $46 | $4 |
| Clonidine | 12 | $45 | $4 |
2020: 59 drugs
| Januvia | 33 | $21,897 | $664 |
| Xarelto | 14 | $10,603 | $757 |
| Spiriva | 14 | $6,524 | $466 |
| Atrovent Hfa | 15 | $5,915 | $394 |
| Sucralfate | 43 | $5,425 | $126 |
| Eliquis | 13 | $5,342 | $411 |
| Lantus Solostar | 13 | $3,268 | $251 |
| Flovent Hfa | 14 | $2,694 | $192 |
| Atorvastatin | 262 | $2,545 | $10 |
| Levothyroxine | 96 | $1,789 | $19 |
| Ventolin Hfa | 27 | $1,479 | $55 |
| Losartan | 128 | $1,311 | $10 |
| Gabapentin | 102 | $1,228 | $12 |
| Albuterol Sulfate Hfa | 25 | $1,174 | $47 |
| Amlodipine Besylate | 233 | $1,023 | $4 |
| Ultra-Fine Short Pen Needle | 13 | $851 | $65 |
| Metformin | 152 | $842 | $6 |
| Metoprolol | 68 | $745 | $11 |
| Omeprazole | 109 | $734 | $7 |
| Oxybutynin Chloride Er | 19 | $714 | $38 |
| Fluticasone Propionate | 67 | $621 | $9 |
| Isosorbide Dinitrate | 12 | $577 | $48 |
| Rosuvastatin | 26 | $565 | $22 |
| Pantoprazole | 60 | $562 | $9 |
| Atenolol | 64 | $519 | $8 |
| Metoprolol | 34 | $485 | $14 |
| Furosemide | 85 | $446 | $5 |
| Propranolol | 26 | $429 | $16 |
| Fosinopril | 27 | $428 | $16 |
| Famotidine | 45 | $423 | $9 |
| Pravastatin | 18 | $401 | $22 |
| Alendronate | 30 | $371 | $12 |
| Simvastatin | 65 | $362 | $6 |
| Doxazosin Mesylate | 12 | $335 | $28 |
| Hydrocodone-Acetaminophen | 31 | $311 | $10 |
| Glipizide | 35 | $310 | $9 |
| Benazepril | 41 | $304 | $7 |
| Montelukast | 52 | $298 | $6 |
| Nitroglycerin | 20 | $283 | $14 |
| Clopidogrel | 19 | $256 | $13 |
| Allopurinol | 27 | $234 | $9 |
| Hydrochlorothiazide | 53 | $191 | $4 |
| Tamsulosin | 40 | $186 | $5 |
| Lisinopril | 45 | $183 | $4 |
| Hydrocortisone | 17 | $177 | $10 |
| Hydralazine | 15 | $170 | $11 |
| Metformin Hcl Er | 30 | $169 | $6 |
| Potassium Chloride | 14 | $144 | $10 |
| Baclofen | 25 | $127 | $5 |
| Clotrimazole | 12 | $124 | $10 |
| Acetaminophen-Codeine | 14 | $119 | $8 |
| Bupropion Xl | 12 | $92 | $8 |
| Trazodone | 19 | $76 | $4 |
| Nortriptyline | 12 | $63 | $5 |
| Fluoxetine | 19 | $61 | $3 |
| Cephalexin | 11 | $55 | $5 |
| Tramadol | 11 | $43 | $4 |
| Ibuprofen | 14 | $38 | $3 |
| Sertraline | 13 | $31 | $2 |
2019: 60 drugs
| Januvia | 31 | $23,120 | $746 |
| Atrovent Hfa | 22 | $8,573 | $390 |
| Spiriva | 15 | $6,746 | $450 |
| Flovent Hfa | 15 | $3,571 | $238 |
| Vascepa | 12 | $3,446 | $287 |
| Atorvastatin | 187 | $2,117 | $11 |
| Arnuity Ellipta | 11 | $1,958 | $178 |
| Ventolin Hfa | 26 | $1,698 | $65 |
| Gabapentin | 90 | $1,694 | $19 |
| Levothyroxine | 94 | $1,562 | $17 |
| Isosorbide Dinitrate | 18 | $1,258 | $70 |
| Albuterol Sulfate Hfa | 23 | $1,103 | $48 |
| Amlodipine Besylate | 144 | $978 | $7 |
| Losartan | 102 | $893 | $9 |
| Metformin | 119 | $893 | $8 |
| Omeprazole | 104 | $890 | $9 |
| Duloxetine | 17 | $816 | $48 |
| Proair Hfa | 16 | $672 | $42 |
| Bupropion Hcl Sr | 16 | $651 | $41 |
| Oxybutynin Chloride Er | 18 | $617 | $34 |
| Metoprolol | 36 | $531 | $15 |
| Metoprolol | 29 | $527 | $18 |
| Pantoprazole | 58 | $490 | $8 |
| Fluticasone Propionate | 53 | $487 | $9 |
| Proctozone-Hc | 21 | $466 | $22 |
| Propranolol | 24 | $460 | $19 |
| Furosemide | 72 | $428 | $6 |
| Tamsulosin | 21 | $418 | $20 |
| Doxazosin Mesylate | 15 | $405 | $27 |
| Benazepril | 43 | $390 | $9 |
| Atenolol | 48 | $384 | $8 |
| Pravastatin | 14 | $376 | $27 |
| Glipizide | 46 | $363 | $8 |
| Hydrocodone-Acetaminophen | 25 | $347 | $14 |
| Simvastatin | 48 | $282 | $6 |
| Alendronate | 28 | $269 | $10 |
| Hydrochlorothiazide | 44 | $237 | $5 |
| Clopidogrel | 16 | $221 | $14 |
| Nitrofurantoin Mono-Macro | 12 | $205 | $17 |
| Acetaminophen-Codeine | 21 | $204 | $10 |
| Montelukast | 30 | $190 | $6 |
| Metformin Hcl Er | 38 | $179 | $5 |
| Nitroglycerin | 14 | $177 | $13 |
| Baclofen | 29 | $175 | $6 |
| Fosinopril | 11 | $168 | $15 |
| Famotidine | 18 | $161 | $9 |
| Diltiazem 24hr Er (Cd) | 13 | $157 | $12 |
| Fluoxetine | 20 | $154 | $8 |
| Carvedilol | 13 | $150 | $12 |
| Trazodone | 20 | $148 | $7 |
| Allopurinol | 16 | $147 | $9 |
| Meclizine | 21 | $132 | $6 |
| Cephalexin | 25 | $132 | $5 |
| Ranitidine | 15 | $131 | $9 |
| Topiramate | 14 | $124 | $9 |
| Lisinopril | 14 | $108 | $8 |
| Hydrocortisone | 17 | $93 | $5 |
| Azithromycin | 11 | $78 | $7 |
| Ibuprofen | 11 | $41 | $4 |
| Tramadol | 12 | $29 | $2 |
2018: 41 drugs
| Januvia | 29 | $21,449 | $740 |
| Atrovent Hfa | 16 | $5,477 | $342 |
| Vascepa | 13 | $3,427 | $264 |
| Ventolin Hfa | 29 | $1,831 | $63 |
| Atorvastatin | 146 | $1,795 | $12 |
| Proair Hfa | 23 | $1,327 | $58 |
| Levothyroxine | 58 | $1,094 | $19 |
| Metformin | 113 | $771 | $7 |
| Omeprazole | 62 | $649 | $10 |
| Amlodipine Besylate | 95 | $614 | $6 |
| Pravastatin | 22 | $567 | $26 |
| Pantoprazole | 59 | $535 | $9 |
| Losartan | 68 | $507 | $7 |
| Hydrocodone-Acetaminophen | 33 | $399 | $12 |
| Propranolol | 18 | $373 | $21 |
| Metoprolol | 40 | $356 | $9 |
| Hydrochlorothiazide | 72 | $339 | $5 |
| Amitriptyline | 11 | $326 | $30 |
| Gabapentin | 34 | $317 | $9 |
| Metoprolol | 19 | $288 | $15 |
| Glipizide | 59 | $263 | $4 |
| Benazepril | 33 | $240 | $7 |
| Atenolol | 35 | $230 | $7 |
| Simvastatin | 43 | $228 | $5 |
| Fluticasone Propionate | 27 | $225 | $8 |
| Acetaminophen-Codeine | 25 | $221 | $9 |
| Montelukast | 19 | $202 | $11 |
| Tamsulosin | 11 | $192 | $17 |
| Alendronate | 23 | $175 | $8 |
| Furosemide | 29 | $174 | $6 |
| Triamcinolone Acetonide | 15 | $150 | $10 |
| Clopidogrel | 15 | $145 | $10 |
| Azithromycin | 18 | $113 | $6 |
| Ranitidine | 12 | $111 | $9 |
| Baclofen | 12 | $107 | $9 |
| Carvedilol | 15 | $106 | $7 |
| Metformin Hcl Er | 17 | $91 | $5 |
| Allopurinol | 14 | $86 | $6 |
| Ibuprofen | 15 | $71 | $5 |
| Cephalexin | 13 | $53 | $4 |
| Tramadol | 11 | $41 | $4 |
2017: 31 drugs
| Januvia | 12 | $7,126 | $594 |
| Symbicort | 17 | $4,864 | $286 |
| Xarelto | 12 | $4,721 | $393 |
| Ventolin Hfa | 25 | $1,324 | $53 |
| Atorvastatin | 71 | $890 | $13 |
| Levothyroxine | 43 | $803 | $19 |
| Propranolol | 21 | $595 | $28 |
| Omeprazole | 59 | $501 | $8 |
| Pravastatin | 24 | $494 | $21 |
| Amlodipine Besylate | 74 | $471 | $6 |
| Metformin | 66 | $468 | $7 |
| Pantoprazole | 40 | $344 | $9 |
| Losartan | 37 | $301 | $8 |
| Hydrocodone-Acetaminophen | 25 | $261 | $10 |
| Metoprolol | 27 | $230 | $9 |
| Simvastatin | 33 | $223 | $7 |
| Enalapril Maleate | 11 | $200 | $18 |
| Fluticasone Propionate | 22 | $185 | $8 |
| Hydrochlorothiazide | 40 | $184 | $5 |
| Alendronate | 29 | $182 | $6 |
| Acetaminophen-Codeine | 19 | $181 | $10 |
| Fosinopril | 15 | $177 | $12 |
| Gabapentin | 24 | $160 | $7 |
| Atenolol | 30 | $159 | $5 |
| Furosemide | 28 | $157 | $6 |
| Clopidogrel | 11 | $128 | $12 |
| Glipizide | 30 | $127 | $4 |
| Montelukast | 17 | $121 | $7 |
| Azithromycin | 20 | $111 | $6 |
| Benazepril | 19 | $105 | $6 |
| Tramadol | 17 | $77 | $5 |
2016: 23 drugs
| Proair Hfa | 26 | $1,391 | $54 |
| Ventolin Hfa | 14 | $665 | $48 |
| Atorvastatin | 35 | $600 | $17 |
| Captopril | 11 | $419 | $38 |
| Fosinopril | 16 | $276 | $17 |
| Pravastatin | 13 | $251 | $19 |
| Metformin | 37 | $247 | $7 |
| Amlodipine Besylate | 35 | $209 | $6 |
| Omeprazole | 19 | $167 | $9 |
| Clopidogrel | 17 | $151 | $9 |
| Hydrochlorothiazide | 17 | $126 | $7 |
| Pantoprazole | 12 | $122 | $10 |
| Glipizide | 17 | $116 | $7 |
| Alendronate | 14 | $112 | $8 |
| Azithromycin | 16 | $95 | $6 |
| Simvastatin | 17 | $89 | $5 |
| Fluticasone Propionate | 11 | $89 | $8 |
| Atenolol | 12 | $80 | $7 |
| Furosemide | 13 | $74 | $6 |
| Benazepril | 11 | $73 | $7 |
| Metoprolol | 12 | $53 | $4 |
| Losartan | 12 | $51 | $4 |
| Gabapentin | 11 | $40 | $4 |
2015: 15 drugs
| Symbicort | 12 | $3,315 | $276 |
| Proair Hfa | 42 | $2,172 | $52 |
| Clonidine | 15 | $1,879 | $125 |
| Atorvastatin | 14 | $175 | $13 |
| Tizanidine | 13 | $174 | $13 |
| Simvastatin | 21 | $145 | $7 |
| Metformin | 24 | $125 | $5 |
| Amlodipine Besylate | 28 | $125 | $4 |
| Gabapentin | 16 | $114 | $7 |
| Hydrochlorothiazide | 18 | $93 | $5 |
| Lisinopril | 16 | $86 | $5 |
| Trazodone | 16 | $73 | $5 |
| Metoclopramide | 13 | $71 | $5 |
| Clopidogrel | 11 | $65 | $6 |
| Sertraline | 11 | $59 | $5 |
2014: 7 drugs
| Proair Hfa | 15 | $836 | $56 |
| Levetiracetam | 14 | $267 | $19 |
| Simvastatin | 29 | $247 | $9 |
| Hydrocodone-Acetaminophen | 13 | $193 | $15 |
| Lisinopril | 27 | $190 | $7 |
| Metformin | 18 | $134 | $7 |
| Carvedilol | 20 | $118 | $6 |
2013: 3 drugs
| Pantoprazole | 12 | $243 | $20 |
| Lisinopril | 16 | $126 | $8 |
| Simvastatin | 12 | $120 | $10 |
Professional record
- NPI
- 1497018972
- Licence
- CA 20A13846
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 261Q00000X (261Q00000X)
- Mailing address
- 1993 Mckee Rd, San Jose, CA, 95116
- NPI first listed
- 2012-06-20
- NPI last updated
- 2023-11-01
- NPI record certified
- 2023-11-01
This is when the NPI record was last certified, not a medical board exam.